DK1150681T3 - Anvendelse af en farmaceutisk sammensætning indeholdende desoxypeganin til behandling af nikotinafhængighed - Google Patents

Anvendelse af en farmaceutisk sammensætning indeholdende desoxypeganin til behandling af nikotinafhængighed

Info

Publication number
DK1150681T3
DK1150681T3 DK00905035T DK00905035T DK1150681T3 DK 1150681 T3 DK1150681 T3 DK 1150681T3 DK 00905035 T DK00905035 T DK 00905035T DK 00905035 T DK00905035 T DK 00905035T DK 1150681 T3 DK1150681 T3 DK 1150681T3
Authority
DK
Denmark
Prior art keywords
desoxypeganine
treatment
pharmaceutical composition
composition containing
nicotine dependence
Prior art date
Application number
DK00905035T
Other languages
English (en)
Inventor
Bodo Asmussen
Thomas Hille
Hans-Rainer Hoffmann
Klaus Opitz
Original Assignee
Hf Arzneimittelforsch Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hf Arzneimittelforsch Gmbh filed Critical Hf Arzneimittelforsch Gmbh
Application granted granted Critical
Publication of DK1150681T3 publication Critical patent/DK1150681T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK00905035T 1999-02-19 2000-02-08 Anvendelse af en farmaceutisk sammensætning indeholdende desoxypeganin til behandling af nikotinafhængighed DK1150681T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19906979A DE19906979B4 (de) 1999-02-19 1999-02-19 Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit

Publications (1)

Publication Number Publication Date
DK1150681T3 true DK1150681T3 (da) 2006-05-22

Family

ID=7898025

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00905035T DK1150681T3 (da) 1999-02-19 2000-02-08 Anvendelse af en farmaceutisk sammensætning indeholdende desoxypeganin til behandling af nikotinafhængighed

Country Status (12)

Country Link
US (1) US6548510B1 (da)
EP (1) EP1150681B1 (da)
JP (1) JP4287596B2 (da)
KR (1) KR100681631B1 (da)
AR (1) AR022621A1 (da)
AT (1) ATE314850T1 (da)
AU (1) AU2670600A (da)
DE (2) DE19906979B4 (da)
DK (1) DK1150681T3 (da)
ES (1) ES2255977T3 (da)
PT (1) PT1150681E (da)
WO (1) WO2000048445A2 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10119863A1 (de) * 2001-04-24 2002-11-07 Hf Arzneimittelforsch Gmbh Verwendung von Desoxypeganin zur Behandlung von psychiatrischen oder zerebralen Krankheitserscheinungen
DE10129265A1 (de) * 2001-06-18 2003-01-02 Hf Arzneimittelforsch Gmbh Wirkstoff-Kombination zur medikamentösen Sucht- oder Rauschmitteltherapie
DE10134038A1 (de) * 2001-07-12 2003-02-06 Hf Arzneimittelforsch Gmbh Wirkstoff-Kombination zur medikamentösen Therapie der Nikotinabhängigkeit
DE10163667B4 (de) * 2001-12-21 2006-10-26 Hf Arzneimittelforschung Gmbh Verwendung von Desoxypeganin zur Behandlung der klinischen Depression
DE10304141B4 (de) 2003-02-03 2006-03-09 Hf Arzneimittelforschung Gmbh Verfahren zur Herstellung von Chinazolin-Alkaloiden
DE10354894A1 (de) * 2003-11-24 2005-07-07 Hf Arzneimittelforschung Gmbh Orale Formulierungen des Desoxypeganins und deren Anwendungen
DE10354893B4 (de) * 2003-11-24 2011-03-10 Hf Arzneimittelforschung Gmbh Verwendung von Desoxypeganin zur Behandlung schizophrener Psychosen
WO2008007163A1 (en) * 2006-07-11 2008-01-17 Adnan Jathlan Al-Rehaily Peganine isolated from anisotes trisulcus l. as a smoking deterrent and anorxigenic agent
US8952038B2 (en) 2010-03-26 2015-02-10 Philip Morris Usa Inc. Inhibition of undesired sensory effects by the compound camphor
EP2552245B1 (en) 2010-03-26 2018-11-14 Philip Morris Products S.A. Inhibition of sensory irritation during consumption of non-smokeable tobacco products
US10335378B2 (en) 2013-03-15 2019-07-02 Altria Client Services Llc Inhibition of central nervous system effects from smoking and sensory effects from smoking
CN104382964B (zh) * 2014-10-27 2017-07-28 上海中医药大学 一种由骆驼蓬草制备骆驼蓬草总生物碱提取物和骆驼蓬草总黄酮提取物的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797494A (en) 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3760805A (en) 1971-01-13 1973-09-25 Alza Corp Osmotic dispenser with collapsible supply container
US3996934A (en) 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US3742951A (en) 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
SU605614A1 (ru) * 1971-10-20 1978-05-05 Ордена Трудового Красного Знамени Институт Химии Растительных Веществ Ан Узбекской Сср Антихолинэстеразное средство
US3987790A (en) 1975-10-01 1976-10-26 Alza Corporation Osmotically driven fluid dispenser
US4031894A (en) 1975-12-08 1977-06-28 Alza Corporation Bandage for transdermally administering scopolamine to prevent nausea
US4137300A (en) 1976-08-20 1979-01-30 Ciba-Geigy Corporation Sustained action dosage forms
DE3315272C2 (de) 1983-04-27 1986-03-27 Lohmann Gmbh & Co Kg, 5450 Neuwied Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
US4597961A (en) 1985-01-23 1986-07-01 Etscorn Frank T Transcutaneous application of nicotine
DE3629304A1 (de) 1986-08-28 1988-03-24 Lohmann Gmbh & Co Kg Transdermales therapeutisches system, seine verwendung und verfahren zu seiner herstellung
DE3843239C1 (da) 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
DE19906977C1 (de) * 1999-02-19 2000-06-15 Lohmann Therapie Syst Lts Desoxypeganin-TTS und seine Verwendung
DE19906974C2 (de) * 1999-02-19 2003-10-09 Lohmann Therapie Syst Lts Verwendung von Desoxypeganin zur Behandlung des Alkoholismus
DE19906975B4 (de) * 1999-02-19 2004-04-15 Lts Lohmann Therapie-Systeme Ag Arzneiform zur Behandlung von Alzheimer'scher Demenz

Also Published As

Publication number Publication date
WO2000048445A3 (de) 2001-04-26
KR20010102240A (ko) 2001-11-15
ES2255977T3 (es) 2006-07-16
AR022621A1 (es) 2002-09-04
JP2002537232A (ja) 2002-11-05
ATE314850T1 (de) 2006-02-15
WO2000048445A2 (de) 2000-08-24
JP4287596B2 (ja) 2009-07-01
DE19906979B4 (de) 2004-07-08
KR100681631B1 (ko) 2007-02-09
US6548510B1 (en) 2003-04-15
EP1150681B1 (de) 2006-01-04
DE19906979A1 (de) 2000-08-31
PT1150681E (pt) 2006-05-31
AU2670600A (en) 2000-09-04
EP1150681A2 (de) 2001-11-07
DE50012014D1 (de) 2006-03-30

Similar Documents

Publication Publication Date Title
DK1158992T3 (da) Anvendelse af xenon til fremstilling af et farmaceutisk præparat til behandling af neurointoksikationer
DK1196163T3 (da) Farmaceutiske sammensætninger til behandling af insulinresistens
DK1093370T3 (da) Farmaceutisk præparat til behandling af diabetes
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
DK2412368T3 (da) Sammensætning til behandling af ar
NO20015175D0 (no) Farmasöytisk sammensetning
DK0941103T3 (da) Farmaceutisk præparat til behandling af diabetes
NO20022970L (no) Hydrogel-drevet medikamentdoseringsform
DK1353919T3 (da) Hidtil ukendte quinuclidinderivater og medicinale sammensætninger indeholdende samme
FI991485A0 (fi) Uusi farmaseuttinen koostumus
DK1674084T3 (da) Forlænget frigivelse af oral dosissammensætning
ATE258928T1 (de) Respiratorisches syncytialvirus replikation inhibitoren
DK1052974T3 (da) Farmaceutisk sammensætning indeholdende epothilon
ATE259796T1 (de) Respiratorisches syncytialvirus replikation inhibitoren
EE05020B1 (et) Glburiidi ravimkoostis
DK1282616T3 (da) Hydroxyphenylpiperidin-4-ylidenmethylbenzamidderivater til behandling af smerter
DK1349580T3 (da) Fremgangsmåde til forbedring af stabiliteten af en farmaceutisk sammensætning
DK0979079T3 (da) Anvendelse af tetrahydropyridinderivater til fremstilling af lægemidler til behandling af sygdomme, der medförer en demyelinisering
DK1150681T3 (da) Anvendelse af en farmaceutisk sammensætning indeholdende desoxypeganin til behandling af nikotinafhængighed
DK1443938T3 (da) Dosisenhed omfattende en prostaglantinanalog til behandling af forstoppelse
NO20014926D0 (no) Farmasöytiske forbindelser
FI20000780A (fi) Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
NO20012976L (no) Anvendelse av inhibitorer av KQTI-kanalen for fremstilling av et medikament
NO20024777D0 (no) Kinolinyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
NO20024776D0 (no) Hydroksyfenyl-piperazinyl-metyl-benzamidderivater til behandling av smerte